Please login to the form below

Not currently logged in

People, May, 2006

Altana Pharma UK has appointed Dr Andrew Saich as medical director. He was most recently at NABI Biopharmaceuticals as medical director

Altana Pharma UK has appointed Dr Andrew Saich as medical director. He was most recently at NABI Biopharmaceuticals as medical director and also, prior to this, at Chiron Vaccines. After working in a number of London hospitals as a junior doctor and spending several years as a registrar in emergency medicine at St Mary's Hospital, Paddington and the Chelsea and Westminster Hospital in Fulham, Dr Saich gained international experience in emergency medicine in Australia. He then joined Procter & Gamble as a medical advisor and successfully completed his diploma in pharmaceutical medicine while he was senior medical adviser at German company, Bayer.

Russell Gibbs, group chief financial officer at Cyprotex, joins the board of the drug discovery firm with immediate effect. He has worked for a number of major investment banks, including UBS, Paribas SA and NatWest, and has advised on initial public offerings, mergers and acquisitions and new fundraising in both the quoted equity and bond markets.

Baxter Healthcare has named David Holliday as vice-president of global marketing operations, bioscience, and he has relocated to Westlake, California. David joined Baxter in early 2003 as business unit director for bioscience UK, following 17 years in various senior sales and marketing roles at Novartis. He was named as Baxter's European Business Director of the Year in February this year.

Biotech firm CellCentric has appointed Dr Tim Fell as chief operating officer. He was previously the co-founder of Oxford Gene Technology with Professor Ed Southern, and later became chief technology officer at Arrow Therapeutics. His new role will focus on the coordination and delivery of assets from CellCentric's discovery base.

Organon Laboratories has appointed Emma Ward as communications manager responsible for external and internal communications in the UK. Emma has more than 14 years' experience in healthcare PR and communications, and was previously at specialist healthcare agency, Pope Woodhead & Associates.  Based in Cambridge, she will report to Organon managing director, Frans Cromme.

Pfizer UK's former head of patient relationship marketing, Di Stafford, has left the company to become an independent consultant focusing on patient marketing, relationship management and communications. She founded her new company, The Patient Practice, at the end of 2005. Di joined Pfizer in 2003 and, for the last six months of her tenure, was also acting head of product communications. At The Patient Practice, she will focus on a range of information and communications projects, including disease awareness, patient compliance, direct-to-patient support and other patient relationship manage-ment programmes.

Ablynx chairman Dr Edwin Moses has accepted the board's offer to extend his role to include that of chief executive officer at the Belgian biopharmaceutical company. He has been non-executive chairman since November 2004. He takes over the CEO role from Mark Vaeck, who will continue to support the company in a consultative capacity. Prior to his time at Ablynx, Dr Moses was CEO and then chairman at Oxford Asymmetry International.

Ian Harvey has been appointed as full-time finance director at York Pharma and will take up the expanded post (from part-time) in October. Prior to joining York in 2004, Ian held a number of finance director positions in both private and public companies. He was also a partner at BDO Stoy Hayward for 17 years, following a stint at Thomson McLintock beginning in 1973.

Penny Mordaunt has joined Diabetes UK as the charity's new director of nations, regions and campaigns. Her previous roles include communications director for Kensington and Chelsea Council and the Freight Transport Association.

Martin Lennon has joined healthcare communications firm Workhouse as director. He was formerly at Wyeth, where he served as assistant vice-president, global strategy. He began his career in the pharma industry at Boehringer Mannheim UK before joining Novartis in 1993. In his most recent role at Wyeth, Martin was responsible for the global marketing of Enbrel.

ScopeMedical has made three new appointments: Kate Glencross joins as senior account manager. She has worked in medical communications for five years for a number of international pharma clients. Sarah Batt joins the editorial team as a medical writer; her research background is in medical microbiology. Finally, Zdenka Husakova joins as a project coordinator.


Kate George has joined Cherry Advertising as an account executive. Previously, Kate worked at IMS Health as an editor for pharmaceutical and biotech publications.

Munro & Forster has announced a new senior structure for its London office: joining from Black Cat, Laura Kinghorn has been appointed as finance director with responsibility for the finance and business support functions. Sarah Hart has been named as business development director, responsible for establishing and developing new service offerings. New heads of practice have also been appointed: Bryony Box is head of healthcare and Ed Gyde has been named as the head of public and voluntary sectors.

Ian Cumming OBE, chief executive of Morecambe Bay Hospitals NHS Trust, has succeeded Dr Peter Simpson as deputy chairman of the Postgraduate Medical Education and Training Board (PMETB).

Virgo Health has appointed three new team members and the agency's first promotions of 2006. Catherine G˙rtin joins as account director and will provide senior support on communications programmes for Lilly and GlaxoSmithKline (GSK) in mental health and diabetes, respectively. She was previously at Ruder Finn. Rachel Hughes joins as senior account executive from the Auckland District Health Board in New Zealand. She will work on the global programme for Roche and GSK's Bonviva. Victoria Boswell-Smith joins as account executive after a year of post-doc' research into respiratory diseases, further to completing her PhD in Pharmacology at King's College, London. Meanwhile, Lisa Rodwell has been promoted to associate director, and Tim Geldard to senior account manager.

Affiniti (UK) has appointed Hillary Carr as group account director to work alongside Nicky Oates, who was recently promoted to the position of client services director and an associate director of the company. Hillary has over 25 years' healthcare communications experience, having worked for agencies including Paling Walters, McCann, Matthew Poppy and DDB. Meanwhile, Sara Robinson has been promoted to senior account executive and Angella Tape joins the agency as account executive.

AstraZeneca UK has appointed Mark Burton as global human resources business partner for the finance strategy team. Mark joined the firm in 2002 as head of HR excellence. He served formerly in the army, rising to the rank of Captain.

Stephen Page, formerly managing director at Core-Create, has joined Medicom Group's newly-formed design and branding consultancy, Medibrand, as managing director. He has co-founded the firm with former Core-Create colleague, Zuleika Burnett, who will be the creative director. Stephen was a founding partners of Core-Create, which was set up after the merger of London firm, Paper White, with Ribotsky Worldwide from the US.


Subscribe to our email news alerts

Featured jobs


Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....